tablets Vestibo are shown in a disease and Menyer's syndrome, characterized by three main symptoms:
- dizziness, sometimes is followed by nausea and vomiting;
- decrease in hearing (relative deafness);
- sonitus.
For symptomatic treatment of vestibular dizziness of various origin.
Structure
Active ingredient: betahistine;
1 tablet supports a betagistin of dihydrochloride of 24 mg;
Excipients: povidone, cellulose microcrystalline, lactose, silicon dioxide colloidal, krospovidon, stearic acid.
Contraindication
Hypersensitivity to or in any of medicament excipients. Pheochromocytoma.
Route of administration
Daily dose for adults makes 24-48 mg, evenly distributed for reception within a day.
Dose should be selected individually, depending on effect. Reduction of symptoms is sometimes observed only after two-three weeks of treatment. The best results are sometimes achieved at administration of medicament within several months. There are data that purpose of treatment at the beginning of a disease prevents its progressing and/or a hearing loss at late stages.
Feature of use
Pregnant
Betagistin should not be applied during pregnancy, except for cases of undoubted need. > Children
it is not recommended by
to p. to Drivers
to
It is contraindicated.
toOverdose
toKnows several cases of overdose of drug. At some patients easy and moderate symptoms (nausea, drowsiness, an abdominal pain) after administration of medicament in a dose up to 640 mg were observed. Serious complications (spasms, cardiopulmonary complications) were observed at intended reception of the raised doses of a betagistin, especially in combination with overdose of other medicines.
Side effects
- from digestive tract. nausea and dyspepsia.
- from nervous system. Headache.
Interaction
As betagistin is a histamine analog, interaction of a betagistin with antihistaminic medicaments can theoretically affect efficiency of one of these drugs.
Storage conditionsto Store
in original packing at a temperature not above 25 °C. to Store
in the places inaccessible for children.
Expiration date - 3 years.
Characteristics | |
Active ingredients | Betagistin |
Amount of active ingredient | 24 mg |
Applicant | Teva |
Code of automatic telephone exchange | N07CA01 Betagistin |
Interaction with food | Later |
Light sensitivity | Not sensitive |
Market status | The branded generic |
Origin | Chemical |
Prescription status | According to the prescription |
Primary packing | blister |
Producer | AT BALKANFARMA DUPNITSYA |
Quantity in packing | 60 tablets (6 blisters on 10 pieces) |
Release form | tablets for internal use |
Route of administration | Oral |
Sign | Import |
Storage temperature | from 5 °C to 25 °C |
Trade name | Vestibo |
Vestibo of the tab. of 24 mg No. 60
- Product Code: 182866
- In Stock
- Ready to ship
-
$67.52